Bolli R (2021) CAESAR’s legacy: a new era of rigor in preclinical studies of cardioprotection. Basic Res Cardiol 116:33. https://doi.org/10.1007/s00395-021-00874-8

Article  PubMed  PubMed Central  Google Scholar 

Bolli RBL, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA, NHLBI Working Group on the Translation of Therapies for Protecting the Heart from Ischemia (2004) Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95:125–134. https://doi.org/10.1161/01.RES.0000137171.97172.d7

Article  CAS  PubMed  Google Scholar 

Bolli R, Tang XL (2022) New insights into cardioprotection, gained by adopting the CAESAR standards of rigor. Basic Res Cardiol 117:57. https://doi.org/10.1007/s00395-022-00964-1

Article  PubMed  Google Scholar 

Botker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femmino S, Garcia-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhauser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schluter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G (2018) Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol 113:39. https://doi.org/10.1007/s00395-018-0696-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brenner GB, Makkos A, Nagy CT, Onodi Z, Sayour NV, Gergely TG, Kiss B, Gorbe A, Saghy E, Zadori ZS, Lazar B, Baranyai T, Varga RS, Husti Z, Varro A, Tothfalusi L, Schulz R, Baczko I, Giricz Z, Ferdinandy P (2020) Hidden cardiotoxicity of rofecoxib can be revealed in experimental models of ischemia/reperfusion. Cells 9:1–17. https://doi.org/10.3390/cells9030551

Article  CAS  Google Scholar 

Bromage DI, Pickard JM, Rossello X, Ziff OJ, Burke N, Yellon DM, Davidson SM (2017) Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis. Cardiovasc Res 113:288–297. https://doi.org/10.1093/cvr/cvw219

Article  CAS  PubMed  Google Scholar 

Dawson D, Lygate CA, Saunders J, Schneider JE, Ye X, Hulbert K, Noble JA, Neubauer S (2004) Quantitative 3-dimensional echocardiography for accurate and rapid cardiac phenotype characterization in mice. Circulation 110:1632–1637. https://doi.org/10.1161/01.CIR.0000142049.14227.AD

Article  PubMed  Google Scholar 

De Hert SG (2005) The concept of anaesthetic-induced cardioprotection: clinical relevance. Best Pract Res Clin Anaesthesiol 19:445–459. https://doi.org/10.1016/j.bpa.2005.02.004

Article  CAS  PubMed  Google Scholar 

dos Santos L, Mello AF, Antonio EL, Tucci PJ (2008) Determination of myocardial infarction size in rats by echocardiography and tetrazolium staining: correlation, agreements, and simplifications. Braz J Med Biol Res 41:199–201. https://doi.org/10.1590/s0100-879x2008005000007

Article  PubMed  Google Scholar 

Ferdinandy P, Andreadou I, Baxter GF, Botker HE, Davidson SM, Dobrev D, Gersh BJ, Heusch G, Lecour S, Ruiz-Meana M, Zuurbier CJ, Hausenloy DJ, Schulz R (2023) Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning. Pharmacol Rev 75:159–216. https://doi.org/10.1124/pharmrev.121.000348

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferdinandy P, Baczko I, Bencsik P, Giricz Z, Gorbe A, Pacher P, Varga ZV, Varro A, Schulz R (2019) Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications. Eur Heart J 40:1771–1777. https://doi.org/10.1093/eurheartj/ehy365

Article  CAS  PubMed  Google Scholar 

Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q, Chuprun JK, Ma XL, Koch WJ (2010) A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107:1445–1453. https://doi.org/10.1161/CIRCRESAHA.110.223925

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grieve SM, Mazhar J, Callaghan F, Kok CY, Tandy S, Bhindi R, Figtree GA (2014) Automated quantification of myocardial salvage in a rat model of ischemia-reperfusion injury using 3D high-resolution magnetic resonance imaging (MRI). J Am Heart Assoc. https://doi.org/10.1161/JAHA.114.000956

Article  PubMed  PubMed Central  Google Scholar 

Hahn JY, Yu CW, Park HS, Song YB, Kim EK, Lee HJ, Bae JW, Chung WY, Choi SH, Choi JH, Bae JH, An KJ, Park JS, Oh JH, Kim SW, Hwang JY, Ryu JK, Lim DS, Gwon HC (2015) Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trial. Am Heart J 169:639–646. https://doi.org/10.1016/j.ahj.2015.01.015

Article  PubMed  Google Scholar 

Hausenloy DJ, Barrabes JA, Botker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, Ibanez B, Iliodromitis EK, Inserte J, Jennings R, Kalia N, Kharbanda R, Lecour S, Marber M, Miura T, Ovize M, Perez-Pinzon MA, Piper HM, Przyklenk K, Schmidt MR, Redington A, Ruiz-Meana M, Vilahur G, Vinten-Johansen J, Yellon DM, Garcia-Dorado D (2016) Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol 111:70. https://doi.org/10.1007/s00395-016-0588-8

Article  PubMed  PubMed Central  Google Scholar 

Hausenloy DJ, Heusch G (2019) Translating cardioprotection for patient benefit: the EU-CARDIOPROTECTION COST action. J Am Coll Cardiol 73:2001–2003. https://doi.org/10.1016/j.jacc.2019.03.020

Article  PubMed  Google Scholar 

Hernandez-Resendiz S, Palma-Flores C, De Los SS, Roman-Anguiano NG, Flores M, de la Pena A, Flores PL, Fernandez GJ, Coral-Vazquez RM, Zazueta C (2015) Reduction of no-reflow and reperfusion injury with the synthetic 17beta-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade. Basic Res Cardiol 110:1. https://doi.org/10.1007/s00395-015-0464-y

Article  CAS  PubMed  Google Scholar 

Heusch G (2017) Critical issues for the translation of cardioprotection. Circ Res 120:1477–1486. https://doi.org/10.1161/CIRCRESAHA.117.310820

Article  CAS  PubMed  Google Scholar 

Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773–789. https://doi.org/10.1038/s41569-020-0403-y

Article  PubMed  Google Scholar 

Heusch G, Botker HE, Ferdinandy P, Schulz R (2023) Primordial non-responsiveness: a neglected obstacle to cardioprotection. Eur Heart J 44:1687–1689. https://doi.org/10.1093/eurheartj/ehad160

Article  PubMed  Google Scholar 

Iyer RP, de Castro Bras LE, Cannon PL, Ma Y, DeLeon-Pennell KY, Jung M, Flynn ER, Henry JB, Bratton DR, White JA, Fulton LK, Grady AW, Lindsey ML (2016) Defining the sham environment for post-myocardial infarction studies in mice. Am J Physiol Heart Circ Physiol 311:H822-836. https://doi.org/10.1152/ajpheart.00067.2016

Article  PubMed  PubMed Central  Google Scholar 

Jones SP, Tang XL, Guo Y, Steenbergen C, Lefer DJ, Kukreja RC, Kong M, Li Q, Bhushan S, Zhu X, Du J, Nong Y, Stowers HL, Kondo K, Hunt GN, Goodchild TT, Orr A, Chang CC, Ockaili R, Salloum FN, Bolli R (2015) The NHLBI-sponsored consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circ Res 116:572–586. https://doi.org/10.1161/CIRCRESAHA.116.305462

Article  CAS  PubMed  Google Scholar 

Kleinbongard P, Arriola CG, Badimon L, Crisostomo V, Giricz Z, Gyongyosi M, Heusch G, Ibanez B, Kiss A, de Kleijn DPV, Podesser BK, Carracedo RR, Rodriguez-Sinovas A, Ruiz-Meana M, Sanchez Margallo FM, Vilahur G, Zamorano JL, Zaragoza C, Ferdinandy P, Hausenloy DJ (2024) The IMproving preclinical assessment of cardioprotective therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning. Basic Res Cardiol 119:893–909. https://doi.org/10.1007/s00395-024-01083-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kukreja R, Tang X-L, Lefer D, Steenbergen C, Jones S, Guo Y, Li Q, Kong M, Stowers H, Hunt G, Tokita Y, Wu W, Ockaili R, Salloum F, Book M, Du J, Bhushan S, Goodchild T, Chang C, Bolli R (2014) Administration of sildenafil at reperfusion fails to reduce infarct size: results from the CAESAR cardioprotection consortium. FASEB J 28:650

Google Scholar 

Lecour S, Andreadou I, Botker HE, Davidson SM, Heusch G, Ruiz-Meana M, Schulz R, Zuurbier CJ, Ferdinandy P, Hausenloy DJ, On behalf of the European Union CCAC (2021) IMproving preclinical assessment of cardioprotective therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action. Basic Res Cardiol 116:52. https://doi.org/10.1007/s00395-021-00893-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lefer DJ, Bolli R (2011) Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation. J Cardiovasc Pharmacol Ther 16:332–339. https://doi.org/10.1177/1074248411414155

Article